UnknownNot Applicable

Accuracy of the Characterization of Adnexal Masses, Indeterminate at Ultrasonography, Using a MRI Protocol Without Contrast: Validation of the Cambridge Score

Italy370 participantsStarted 2021-09-01

Plain-language summary

The aim of this prospective observational study is to evaluate the accuracy and to validate the Cambridge Score,a Test Index to predict the malignancy of the ovarian lesions on the basis of an MRI examination without contrast

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age \> 18 years; * Indeterminate adnexal masses at the ultrasonography; * Signed Informed Consent. Exclusion Criteria: * Diagnosis of an extraovary mass; * Synchronous tumors; * Previous history of neoplasy.

What they're measuring

Evaluation of generalizability of the Cambridge Score through external validations

Timeframe: Through study completion, an average of 3 years

Trial details

NCT IDNCT05815992

SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-12

View on ClinicalTrials.gov More Adnexal Mass trials